Literature DB >> 28105238

Immune-associated proteins with potential in vivo anti-tumor activities are upregulated in lung cancer cells treated with umbelliprenin: A proteomic approach.

Narges Khaghanzadeh1, Kazuyuki Nakamura2, Yasuhiro Kuramitsu2, Abbas Ghaderi3, Zahra Mojtahedi3.   

Abstract

Umbelliprenin (Umb), a natural coumarin, has demonstrated anti-tumor activities, both in vitro and particularly in vivo, in several types of cancer, including lung cancer. The present study aimed to identify molecular targets of Umb using a high-throughput approach. Lung cancer cell lines, QU-DB (large-cell lung carcinoma) and A549 (adenocarcinoma), were treated with Umb. Differentially-expressed proteins were identified using two-dimensional electrophoresis coupled to mass spectrometry. In the QU-DB cells, differential expression of proteins, including downregulation of the tumorigenic protein heat shock protein 90 kDa and upregulation of the potential anti-tumor proteins Nipsnap1 and glycine-tRNA ligase (GRS), suggested that Umb is a strong anti-tumor compound. In the A549 cells, differential expression of proteins indicated possible contradictory effects of Umbregarding tumorigenesis, which included downregulation of the tumorigenic protein cyclophilin and the tumor suppressor MST, and upregulation of stathmin (tumorigenic) and calreticulin. Calreticulun, in addition to GRS in QU-DB cells, stimulates anti-tumor immune responses in vivo. To the best of our knowledge, the present study is the first to use a high-throughput approach to identify targets of Umb in cancer. These molecular targets suggested that Umb may exhibit stronger in vitro anti-tumor activity against the large-cell carcinoma model than the adenocarcinoma model. Furthermore, it has been reported that Umb exhibits higher cytotoxicity against QU-DB cells than A549 cells in vitro, and significant Umb anti-tumor activity against lung cancer in vivo, which is consistent with previously published literature. In each cell type, immune-associated molecules were upregulated, indicating that this naturally occurring compound exhibits marked anti-tumor activity in vivo. However, further studies that investigate the effect of Umb in different in vitro models of cancer are required.

Entities:  

Keywords:  coumarin; immune system; proteomics; umbelliprenin

Year:  2016        PMID: 28105238      PMCID: PMC5228441          DOI: 10.3892/ol.2016.5352

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  34 in total

1.  Covalent and allosteric inhibitors of the ATPase VCP/p97 induce cancer cell death.

Authors:  Paola Magnaghi; Roberto D'Alessio; Barbara Valsasina; Nilla Avanzi; Simona Rizzi; Daniela Asa; Fabio Gasparri; Liviana Cozzi; Ulisse Cucchi; Christian Orrenius; Paolo Polucci; Dario Ballinari; Claudia Perrera; Antonella Leone; Giovanni Cervi; Elena Casale; Yang Xiao; Chihunt Wong; Daniel J Anderson; Arturo Galvani; Daniele Donati; Tom O'Brien; Peter K Jackson; Antonella Isacchi
Journal:  Nat Chem Biol       Date:  2013-07-28       Impact factor: 15.040

2.  4-year mortality in patients with non-small-cell lung cancer: development and validation of a prognostic index.

Authors:  François Blanchon; Michel Grivaux; Bernard Asselain; François-Xavier Lebas; Jean-Pierre Orlando; Jacques Piquet; Mahmoud Zureik
Journal:  Lancet Oncol       Date:  2006-10       Impact factor: 41.316

3.  Caspase cleavage of vimentin disrupts intermediate filaments and promotes apoptosis.

Authors:  Y Byun; F Chen; R Chang; M Trivedi; K J Green; V L Cryns
Journal:  Cell Death Differ       Date:  2001-05       Impact factor: 15.828

4.  Overexpression of the glucose-regulated stress gene GRP78 in malignant but not benign human breast lesions.

Authors:  P M Fernandez; S O Tabbara; L K Jacobs; F C Manning; T N Tsangaris; A M Schwartz; K A Kennedy; S R Patierno
Journal:  Breast Cancer Res Treat       Date:  2000-01       Impact factor: 4.872

Review 5.  Studies on coumarins and coumarin-related compounds to determine their therapeutic role in the treatment of cancer.

Authors:  Aoife Lacy; Richard O'Kennedy
Journal:  Curr Pharm Des       Date:  2004       Impact factor: 3.116

6.  Auraptene from Ferula szowitsiana protects human peripheral lymphocytes against oxidative stress.

Authors:  Fatemeh Soltani; Fatemeh Mosaffa; Mehrdad Iranshahi; Gholamreza Karimi; Mohammad Malekaneh; Fatemeh Haghighi; Javad Behravan
Journal:  Phytother Res       Date:  2010-01       Impact factor: 5.878

7.  Secretomic analysis of large cell lung cancer cell lines using two-dimensional gel electrophoresis coupled to mass spectrometry.

Authors:  Zahra Yousefi; Jamal Sarvari; Kazuyuki Nakamura; Yasuhiro Kuramitsu; Abbas Ghaderi; Zahra Mojtahedi
Journal:  Folia Histochem Cytobiol       Date:  2012-10-08       Impact factor: 1.698

8.  Cancer chemopreventive activity of the prenylated coumarin, umbelliprenin, in vivo.

Authors:  Mehrdad Iranshahi; Amirhossein Sahebkar; Midori Takasaki; Takao Konoshima; Harukuni Tokuda
Journal:  Eur J Cancer Prev       Date:  2009-09       Impact factor: 2.497

9.  The mitogen-activated protein kinase phosphatase vaccinia H1-related protein inhibits apoptosis in prostate cancer cells and is overexpressed in prostate cancer.

Authors:  Yke Jildouw Arnoldussen; Petra I Lorenzo; Maria E Pretorius; Håkon Waehre; Bjørn Risberg; Gunhild M Maelandsmo; Håvard E Danielsen; Fahri Saatcioglu
Journal:  Cancer Res       Date:  2008-11-15       Impact factor: 12.701

Review 10.  The functional role of the novel biomarker karyopherin α 2 (KPNA2) in cancer.

Authors:  Anders Christiansen; Lars Dyrskjøt
Journal:  Cancer Lett       Date:  2012-12-23       Impact factor: 8.679

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.